PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
National Research Corporation (NRC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US6373722023

CUSIP

637372202

Sector

Healthcare

IPO Date

Oct 10, 1997

Highlights

Market Cap

$407.07M

EPS (TTM)

$1.12

PE Ratio

15.48

Total Revenue (TTM)

$106.15M

Gross Profit (TTM)

$60.61M

EBITDA (TTM)

$30.13M

Year Range

$16.63 - $41.15

Short %

3.07%

Short Ratio

3.79

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
NRC vs. COST
Popular comparisons:
NRC vs. COST

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in National Research Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-23.49%
5.98%
NRC (National Research Corporation)
Benchmark (^GSPC)

Returns By Period

National Research Corporation had a return of -1.70% year-to-date (YTD) and -54.72% in the last 12 months. Over the past 10 years, National Research Corporation had an annualized return of 5.01%, while the S&P 500 had an annualized return of 11.33%, indicating that National Research Corporation did not perform as well as the benchmark.


NRC

YTD

-1.70%

1M

-9.78%

6M

-23.49%

1Y

-54.72%

5Y*

-22.50%

10Y*

5.01%

^GSPC (Benchmark)

YTD

0.62%

1M

-1.93%

6M

5.98%

1Y

23.72%

5Y*

12.67%

10Y*

11.33%

*Annualized

Monthly Returns

The table below presents the monthly returns of NRC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.40%2.34%-1.46%-13.53%-18.01%-17.84%11.07%-10.55%0.81%-20.69%8.44%-9.67%-54.49%
202324.45%-2.71%-3.39%0.05%3.15%-2.83%-1.38%-2.59%8.79%-4.76%-1.96%-4.22%9.63%
20220.19%-4.38%0.28%-13.49%4.64%7.31%-0.99%-10.00%17.37%2.34%-4.89%-3.40%-8.23%
20215.96%14.06%-9.37%9.82%-6.76%-3.79%14.99%2.31%-21.69%2.68%-7.51%3.96%-1.83%
20202.62%-18.74%-16.88%13.43%9.94%2.63%-1.75%-2.08%-12.13%5.26%-0.95%-16.68%-34.84%
20194.82%-2.63%-0.36%2.54%28.83%13.34%17.07%-5.03%-9.52%-0.55%12.33%2.54%75.47%
20180.94%-24.83%3.72%11.79%5.35%9.06%1.47%3.16%-0.97%-1.42%4.78%-2.61%5.40%
2017-8.16%6.88%6.16%25.89%-3.23%12.50%9.29%9.86%17.03%-0.40%-9.59%10.16%99.10%
2016-5.92%-0.79%4.44%-7.46%-4.79%0.59%9.64%5.39%3.43%-5.77%4.23%19.41%21.08%
2015-1.00%0.36%4.03%0.14%-3.05%2.08%4.15%-13.85%-5.88%28.39%0.85%6.59%19.38%
2014-20.30%16.67%-5.20%-5.00%-4.50%-7.04%-5.58%5.90%-7.00%22.14%-10.89%-0.78%-25.34%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NRC is 4, meaning it’s performing worse than 96% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NRC is 44
Overall Rank
The Sharpe Ratio Rank of NRC is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of NRC is 22
Sortino Ratio Rank
The Omega Ratio Rank of NRC is 22
Omega Ratio Rank
The Calmar Ratio Rank of NRC is 77
Calmar Ratio Rank
The Martin Ratio Rank of NRC is 99
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for National Research Corporation (NRC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for NRC, currently valued at -1.33, compared to the broader market-4.00-2.000.002.00-1.331.92
The chart of Sortino ratio for NRC, currently valued at -2.09, compared to the broader market-4.00-2.000.002.004.00-2.092.57
The chart of Omega ratio for NRC, currently valued at 0.73, compared to the broader market0.501.001.502.000.731.35
The chart of Calmar ratio for NRC, currently valued at -0.74, compared to the broader market0.002.004.006.00-0.742.86
The chart of Martin ratio for NRC, currently valued at -1.42, compared to the broader market-10.000.0010.0020.00-1.4212.10
NRC
^GSPC

The current National Research Corporation Sharpe ratio is -1.33. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of National Research Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-1.33
1.92
NRC (National Research Corporation)
Benchmark (^GSPC)

Dividends

Dividend History

National Research Corporation provided a 2.77% dividend yield over the last twelve months, with an annual payout of $0.48 per share.


0.00%1.00%2.00%3.00%4.00%$0.00$0.50$1.00$1.5020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.48$0.48$1.48$0.84$0.48$0.21$0.78$1.13$0.40$0.34$0.62$0.06

Dividend yield

2.77%2.72%3.74%2.25%1.16%0.49%1.18%2.96%1.07%1.79%3.87%0.43%

Monthly Dividends

The table displays the monthly dividend distributions for National Research Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00
2024$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.48
2023$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$1.12$0.00$0.00$0.12$1.48
2022$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.12$0.84
2021$0.00$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.48
2020$0.00$0.00$0.21$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.21
2019$0.00$0.00$0.19$0.00$0.00$0.19$0.00$0.00$0.19$0.00$0.00$0.21$0.78
2018$0.00$0.00$0.10$0.00$0.00$0.17$0.00$0.00$0.17$0.00$0.00$0.69$1.13
2017$0.00$0.00$0.10$0.00$0.00$0.10$0.00$0.00$0.10$0.00$0.00$0.10$0.40
2016$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.10$0.34
2015$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.44$0.62
2014$0.06$0.06

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%2.8%
National Research Corporation has a dividend yield of 2.77%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%42.7%
National Research Corporation has a payout ratio of 42.74%, which is quite average when compared to the overall market. This suggests that National Research Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-73.02%
-2.82%
NRC (National Research Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the National Research Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the National Research Corporation was 73.62%, occurring on Dec 19, 2024. The portfolio has not yet recovered.

The current National Research Corporation drawdown is 73.02%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-73.62%Jan 29, 20201233Dec 19, 2024
-41.14%May 29, 2013592Oct 1, 2015315Dec 30, 2016907
-26.4%Jan 26, 201823Feb 28, 201878Jun 20, 2018101
-18.55%Oct 4, 201731Nov 15, 201747Jan 25, 201878
-17.01%Aug 1, 201954Oct 16, 201948Dec 24, 2019102

Volatility

Volatility Chart

The current National Research Corporation volatility is 10.02%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
10.02%
4.46%
NRC (National Research Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of National Research Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for National Research Corporation.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab